RecruitingPhase 3NCT06430801
A Study to Evaluate the Efficacy and Safety of Tulisokibart (MK-7240) in Participants With Moderate to Severe Crohn's Disease (MK-7240-008)
Sponsor: Merck Sharp & Dohme LLC
Dallas, TX · Denton, TX · +84 more sites
2 recruiting crohn's disease studies with a site in Denton, TX.
Sponsor: Merck Sharp & Dohme LLC
Dallas, TX · Denton, TX · +84 more sites
Sponsor: Morphic Therapeutic, Inc. (A Wholly Owned Subsidiary of Eli Lilly and Company)
Cedar Park, TX · Denton, TX · Houston, TX · +22 more sites
Listings come from ClinicalTrials.gov and are provided for information only. Always confirm eligibility with the study team and talk with your doctor before making decisions about your care.